Jamie Perse
Stock Analyst at Goldman Sachs
(2.57)
# 2,103
Out of 5,172 analysts
67
Total ratings
54.76%
Success rate
12.01%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Jamie Perse
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| AGL agilon health | Maintains: Neutral | $2.5 → $5 | $0.43 | +1,072.88% | 7 | May 8, 2025 | |
| THC Tenet Healthcare | Maintains: Neutral | $134 → $154 | $200.35 | -23.13% | 12 | May 5, 2025 | |
| LFST LifeStance Health Group | Upgrades: Buy | $10 | $6.40 | +56.25% | 7 | Dec 16, 2024 | |
| OPCH Option Care Health | Downgrades: Neutral | $38 → $27 | $28.16 | -4.12% | 3 | Nov 5, 2024 | |
| CON Concentra Group Holdings Parent | Initiates: Buy | $32 | $21.66 | +47.74% | 1 | Aug 19, 2024 | |
| BTSG BrightSpring Health Services | Maintains: Buy | $21 → $18 | $41.21 | -56.32% | 3 | Aug 9, 2024 | |
| UHS Universal Health Services | Maintains: Buy | $200 → $229 | $185.82 | +23.24% | 16 | Jul 30, 2024 | |
| INNV InnovAge Holding | Maintains: Neutral | $8 → $7 | $7.75 | -9.68% | 5 | Feb 8, 2024 | |
| HCA HCA Healthcare | Downgrades: Neutral | n/a | $493.88 | - | 10 | Dec 11, 2023 | |
| EHAB Enhabit | Maintains: Neutral | $15 → $13 | $13.62 | -4.55% | 2 | Jul 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $32 | $21.24 | +50.66% | 1 | Feb 3, 2023 |
agilon health
May 8, 2025
Maintains: Neutral
Price Target: $2.5 → $5
Current: $0.43
Upside: +1,072.88%
Tenet Healthcare
May 5, 2025
Maintains: Neutral
Price Target: $134 → $154
Current: $200.35
Upside: -23.13%
LifeStance Health Group
Dec 16, 2024
Upgrades: Buy
Price Target: $10
Current: $6.40
Upside: +56.25%
Option Care Health
Nov 5, 2024
Downgrades: Neutral
Price Target: $38 → $27
Current: $28.16
Upside: -4.12%
Concentra Group Holdings Parent
Aug 19, 2024
Initiates: Buy
Price Target: $32
Current: $21.66
Upside: +47.74%
BrightSpring Health Services
Aug 9, 2024
Maintains: Buy
Price Target: $21 → $18
Current: $41.21
Upside: -56.32%
Universal Health Services
Jul 30, 2024
Maintains: Buy
Price Target: $200 → $229
Current: $185.82
Upside: +23.24%
InnovAge Holding
Feb 8, 2024
Maintains: Neutral
Price Target: $8 → $7
Current: $7.75
Upside: -9.68%
HCA Healthcare
Dec 11, 2023
Downgrades: Neutral
Price Target: n/a
Current: $493.88
Upside: -
Enhabit
Jul 17, 2023
Maintains: Neutral
Price Target: $15 → $13
Current: $13.62
Upside: -4.55%
Feb 3, 2023
Initiates: Buy
Price Target: $32
Current: $21.24
Upside: +50.66%